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Abstract 
 
ABSTRACT 
Diuretics are the mainstay of therapy for a variety of diseases ranging from 
hypertension to the nephrotic syndrome. The main objective of the study is to assess 
the utilization pattern of diuretics in a tertiary care hospital in Coimbatore. A 
prospective observational study was conducted for a period of ten months from 
november 2016 to august 2017 in general medicine department and intensive care unit 
of  sri ramakrishna hospital, coimbatore. A total of 100 prescriptions were analysed. 
Through the current study, we could assess the drug utilization pattern of diuretics in 
ICU and general medicine department. The study report shows male population was 
higher compared to females. Diabetes mellitus and systemic hypertension were the 
predominal diagnosis in ICU and general medicine department. ACE inhibitors and 
diuretics were the most frequently utilized drugs in the study. Among diuretics, 
frusemide, spironolactone and mannitol were highly utilized in ICU and general 
Medicine Department. Since diuretic induced electrolyte imbalance were observed 
during the current study, the clinical pharmacist can be effectively employed to 
monitor the electrolyte levels to reduce the adverse effects. The current study assessed 
the major drug interactions which were found to be highly significant. Identifying and 
monitoring drug interactions has a significant part in forming a standard therapeutic 
plan will reduce the occurrence of adverse events. 
 
 
 
 
 
 
 
 
LITERATURE REVIEW 
Marouane Boukhris et al (2017)14 performed a study on the actual 
place of diuretics in hypertension treatment. Diuretics are widely used, and 
have several indications in different cardiovascular disorders, particularly in 
hypertension and heart failure. Despite the large number of available anti-
hypertensive drugs, diuretics remained a cornerstone of hypertension 
treatment. Prescribing diuretics to hypertensive patients seems to be rational 
and appropriate for a better clinical benefit. 
 
Kristopher R Maday et al (2017)15 conducted a study on understanding 
electrolytes, an important diagnostic clue to patient status. Relates the 
pathophysiological alterations and counter-regulatory pathways linked to 
electrolyte imbalances. Knowing the concentration of solutes in the blood 
provides the clinician with meaningful information about the patient’s volume 
status, acid-base status and baseline renal function. 
 
David H Ellison et al (2017)16 performed a study on time course of loop 
and thiazide diuretic-induced electrolyte complications. Therapy with a loop 
or thiazide type diuretic may be associated with a variety of fluid and 
electrolyte complications, including volume depletion, azotemia, 
hypokalemia, metabolic alkalosis, hyponatremia, hyperuricemia, and 
hypomagnesemia. In addition, the potassium-sparing diuretics can induce 
hyperkalemia and metabolic acidosis, while carbonic anhydrase inhibitors 
such as acetazolamide can cause hypokalemia and metabolic acidosis. 
 
Donald A Sones et al (2017)17 performed a study on the effect of 
thiazide diuretics on plasma volume, body electrolytes, and excretion of  
aldosterone in hypertension. This study was undertaken in an effort to acquire 
more information regarding possible mechanisms by which thiazide diuretics 
reduce the blood pressure of hypertensive patients. 
Mathew George et al (2017)18 performed the study effect of thiazide and 
loop diuretics on serum magnesium and other electrolytes in cardiac patients. 
Thiazide and loop diuretics have shown to cause alterations in serum 
magnesium and other electrolyte levels resulting in fatal complications like 
ventricular arrhythmias, coronary artery vasospasm or sudden death. By this 
review we aim at reinforcing the importance of magnesium supplementation 
and the importance of including serum magnesium among the frequently 
monitored parameters, in the cardiac department.  
 
Thomas Taylor (2017)19 studied the monitoring of diuretic use. When 
thiazide and loop diuretics are used, physicians commonly monitor potassium 
levels in the blood and prescribe potassium supplements when necessary. 
Another group of diuretics, known for their “potassium-sparing” effects, 
includes triamterene, spironolactone and amiloride. Most diuretic drugs are 
taken once or twice daily. For prescriptions to be used once a day, the diuretic 
should be taken in the morning. For twice a day use, the diuretic should be 
taken in the morning and in the afternoon. Because most diuretics can cause 
urination lasting several hours, each dosage method will usually keep patients 
from getting up during the night to pass urine.  
 
George C Roush et al (2016)20 reviewed and updated the study on 
diuretics for hypertension. This review and update focuses on the clinical 
features of hydrochlorothiazide, chlorthalidone, indapamide, potassium-
sparing inhibitors and aldosterone receptor antagonists, and loop diuretics. 
Diuretics are the second most commonly prescribed class of antihypertensive 
medication, and  thiazide related diuretics have increased at a rate greater than 
that of antihypertensive medications as a whole.   
 
L K M De Bruyne (2016)12 conducted a study on the mechanism and 
management of diuretic resistance in congestive heart failure. It may be caused 
by decreased renal function and delayed peak concentrations of loop diuretics 
in the tubular fluid, but it can be observed in the presence of pharmacokinetic 
properties. Removal of excessive fluid is usually achieved by a combination of 
salt restriction and loop diuretics, but in some cases edema persists despite 
adequate diuretic therapy. The diuretic resistance can be managed by dose 
adjustment, intravenous bolus injection or continuous infusion of a loop 
diuretic, and by combination diuretic therapy, also discontinue NSAID’s. 
 
Sonia Gulati (2016)21 studied on the role of electrolytes in the body. 
Electrolytes are the minerals found in body fluids that carry an electric charge 
and are essential to keeping the heart, nerves and muscles functioning 
properly. It is important to maintain a precise and constant balance of 
electrolytes to stay healthy. The kidneys play an important role in ensuring 
that electrolytes remain invariant despite any changes may undergo. An 
electrolyte imbalance may be caused by loss of body fluids, poor diet, mal 
absorption, hormonal or endocrine disorders, kidney disease and certain 
medications like diuretics, antibiotics, corticosteroids and chemotherapy 
drugs. Treatments include intravenous fluids and dietary changes.  
Jaap A.Joles et al (2016)22 conducted a complicated triangle study of 
chronic kidney disease, fluid overload and diuretics. Progressive loss of renal 
function causes reduced sodium filtration and inappropriate suppression of 
tubular reabsorption that ultimately lead to volume expansion. Various 
guidelines suggest the use of loop (GFR<30ml/min/1.73m2) and thiazide 
diuretics (GFR >30ml/min/1.73m2) in CKD patients. In conclusion, current 
study demonstrates that diuretic use is an independent predictor of adverse 
renal outcomes in NDD-CKD patients causing decline in eGFR and increasing 
the risk of RRT initiation.  
William J Elliott et al (2016)23 studied loop diuretics are most 
appropriate for hypertension treatment in chronic kidney disease. Torsemide 
should be used more frequently today because of its longer duration of action, 
especially in patients with advanced CKD, its consistent oral bioavailabilty, 
and recent generic availability. In contrast, furosemide and other loop diuretics 
acutely inhibited the Na-K-2Cl cotransporter in the thick ascending limp of the 
loop of Henle, increasing the fractional excretion of sodium by 20%, largely 
independent of the level of renal function. 
 
Jozine M et al (2015)24 studied on the diuretic response in acute heart 
failure includes pathophysiology, evaluation and therapy. The administration 
of loop diuretics to achieve decongestion is the cornerstone of therapy for 
acute heart failure. Unfortunately, impaired response to diuretics is common in 
these patients and associated with adverse outcomes. The study reveals that 
the pathophysiological background of diuretic resistance, evaluation and 
definition of diuretic response, as well as current and future strategies to 
improve diuretic response in patients with acute heart failure. 
 
Shrenik Doshi et al (2015)25 studied on the prevalence of thiamine 
deficiency in heart failure patients on long-term diuretic therapy. It has been 
shown that loop diuretics cause thiamine deficiency by increasing its urinary 
loss. Very low thiamine levels (<0.1 ng/ml) was significantly more common in 
patients with loop diuretics. Use of par-boiled rice in place of polished rice 
and food fortification with thiamine would be the option to prevent this 
deficiency. Two-third of study population was thiamine deficient.  
 
Ahmed Hassan Qavi et al (2015)7  studied on the clinical use of 
diuretics in heart failure, cirrhosis and nephrotic syndrome. Effective and 
adequate diuresis can be achieved in patients with cardiac failure, cirrhosis and 
nephritic syndrome with ideal therapeutic approach of diuretic therapy. 
Therapy should be directed first to the primary disease mechanism. Each 
underlying disorder influences the action of the diuretic being administered, 
Therefore, correct choice of drug is essential for successful management with 
ascites. These diseases lead to sodium and water retention in patients causing 
determined effects in their morbidity and mortality. Treatment of ascites in 
liver cirrhosis with spironolactone as the primary agent is highlighted with 
further therapeutic options. 
 
Larry A Allen (2015)26 conducted a study on the simultaneous use of 
intravenous fluids and diuretics in patients hospitalized with heart failure. The 
delivery of IV fluids among congested patients with heart failure reflects 
variations in the culture of care. Pointing out the frequency with which U.S. 
hospitals give IV fluid and loop diuretics to patients presenting with 
worsening heart failure suggests a way forward to our goal of improving acute 
care.  
 
Jeffrey Freund et al (2015)27 performed a study on the risk of gout with 
the use of thiazide diuretics. Thiazide diuretics may be used in most patients 
with hypertension who have only minimally increased risk of gout. Usual 
doses of thiazides (less than 25 mg) are not associated with an increased risk 
of gout, although doses of 25 mg or greater are. The risk of gout with 
hydrochlorothiazide and chlorthalidone is similar. Thiazides may be used in 
patients with asymptomatic hyperuricemia because they are not associated 
with an increased risk of gout in these patients. 
 
Jainaf Anchiya et al (2014)27 studied on the utilization pattern of anti-
hypertensive medications on out-patients and inpatients in a tertiary care 
teaching hospital: a cross sectional study.11.4% were prescribed with 
diuretics. The clinical pharmacists can be effectively employed for rationality 
use of medication in hypotensive population on a routine basis. Diuretics 
prescribed in single therapy, dual therapy and triple therapy with ACE 
inhibitors, calcium channel blockers and beta blockers. The diuretics  
prescribed in this study was hydrochlorthiazide and furosemide. ACE 
inhibitors were most frequently utilized and amlodipine was the highest 
consumed drug in this study. 
Mabel Bolos (2014)28 performed  a clinical trial to compare the 
effectiveness of diuretics in hemodialysis patients with residual renal function. 
When starting the haemodialysis, the patient holds the residual renal function 
which is lost over time. To preserve the residual renal function, the patient is 
treated with diuretics loops and thiazide diuretics. The effect of this treatment 
is lost when renal function worsens. The treatment with frusemide and 
hydrochlorothiazide in hemodialysis patients with RRF could to decrease in 
weight gain between hemodialysis sessions, to increase urine volume, to 
decrease the ultrafiltration in haemodialysis sessions. 
 
Fidelia Bode – Thomas (2014)29 performed a study on serum 
electrolytes in children on chronic diuretic therapy for heart failure. They 
interfere with the reabsorption of sodium, potassium, and chloride ions and 
also calcium and magnesium ions and may deplete the blood levels of these 
electrolytes. They may also result in acidosis as a result of the body's attempt 
to compensate for hypokalemia by exchanging hydrogen for potassium ions at 
the distal convoluted tubule.  
 
Spyridon Arampatzis et al (2013)30  studied on the impact of diuretic 
therapy associated electrolyte disorders present on admission to the emergency 
department. Diuretics are among the most commonly prescribed medication, 
and due to their mechanisms of action, electrolyte disorders are common side 
effects of their use. The study also reveals the association between diuretics 
being taken and the prevalence of electrolyte disorders on admission as well as 
the impact of electrolyte disorders on patient outcome such as hyponatremia, 
hypernatremia, hypokalemia, hyperkalemia. 
 
Annie Claire et al (2013)31 conducted a study on fluid management and 
use of diuretics in acute kidney injury. Critically ill adult patients at risk for or 
with acute kidney injury require careful attention to their hemodynamic status 
because hypotension and hypovolemia may contribute to or worsen kidney 
injury. The efficacy of these procedures in critically ill , patients need to be 
confirmed with randomized controlled trials. This review focuses on early 
volume resuscitation, overall fluid management, and use of diuretics in 
critically ill adult patients at risk for or with acute kidney injury and their 
effect on mortality and kidney function in this setting. 
 
Jyotsna Rimal et al (2013)32 performed a study on acute hyperkalemia 
and hyponatremia following intraoperative mannitol administration. 
Intravenous mannitol may lead to electrolyte disturbances involving sodium 
and potassium and resulting in cardiac dysfunction. This report demonstrates 
that when mannitol is given during intracranial surgery it can cause large 
increase potassium ion concentration and decrease in sodium ion 
concentration in the absence of any other possible causes. Intraoperative 
checks of serum electrolyte levels, arterial blood gas analysis 
and electrocardiogram monitoring could be recommended to be done routinely 
when using mannitol. 
 
Mishra Snigha et al (2013)8 studied on the review on recent advances in 
a modern day treatment diuretic therapy. Diuretics continued to be a good 
modern day option for lowering blood pressure, edema, congestive heart 
failure, cirrhosis, autism, toxemia. For the majority of patients, diuretics can 
be used as first line therapy.  The choice of drugs to initiate therapy for the 
management of hypertension remains contentious and diuretics are central to 
its controversy. Thiazides were the first tolerated efficient anti-hypertensive 
drugs that significantly reduces cardiovascular system morbidity and mortality 
in placebo-controlled clinical studies. 
 
Sharon J Nessim et al (2013)33 conducted a case- control study on the 
concurrent use of diuretics, angiotensin converting enzyme inhibitors, and 
angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and 
risk of acute kidney injury. The risk was greatest at the start of treatment. 
Although antihypertensive drugs have cardiovascular benefits, vigilance may 
be warranted when they are used concurrently with NSAIDs.  
 
OP Kalra et al (2012)34 performed the study on rational use of diuretics 
and pathophysiology of edema. High doses of loop diuretics can increase urine 
production in patients with chronic renal failure. Continuous infusion of loop 
diuretics offer potential benefits compared with intermittent bolus dosing. 
Treatment of diuretic resistance may require high doses of loop diuretics, a 
combination of loop and thiazide diuretics, or loop diuretics with albumin 
infusions. The level of glomerular filtration rate and need for reduction in ECF 
volume dictates the choice of diuretic agent.  
Michael Mc Evoy (2011)35 assessed the relationship of high blood 
pressure, dehydration and electrolyte imbalance. There is an intrinsic link 
between chronic hypertension, renal failure, dehydration and a deficiency of 
certain electrolyte minerals. Water and electrolytes are absolutely two of the 
most critical components of normal, physiological function. Without a correct 
balance of fluid and electrolytes, the cells of our body lack the essential 
electrical conductivity necessary for cellular energy production. When fluid 
retention accompanies hypertension, it is a primary indicator of intracellular 
fluid loss, and an accumulation of extracellular tissue fluids.  
Robert F Reilly et al (2010)36 studied the use of thiazide diuretics in 
hypertension and nephrolithiasis. Future studies examining the role of low-
dose thiazides on calcium-containing kidney stone recurrence would be of 
interest. In hypertension, chlorthalidone (12.5 to 30 mg daily) may the best 
option for initial therapy, with indapamide (1.5 mg daily) being a valuable 
alternative for older patients. When adding a thiazide to other drug classes, 
indapamide (2.5 mg daily) has clear value in hypertensive patients who have 
had a stroke, and HCTZ (12.5 to 25 mg daily) has a safe track record in 
several groups.  
Allan S et al (2010)37 performed a study on thiazide diuretics and 
primary hyperparathyroidism. This study suggests that thiazide diuretics can 
be given safely to patients with primary hyperparathyroidism. In fact, thiazide-
induced reduction in hypercalciuria might benefit patients by lowering risk for 
calcium kidney stone formation. However, serum calcium levels still should 
be monitored periodically, because they occasionally will increase further 
when patients with primary hyperparathyroidism receive thiazide diuretics. 
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SCOPE OF THE STUDY 
Diuretics are the mainstay of therapy for a variety of diseases ranging from 
hypertension to the nephrotic syndrome. In the aging population, the number of 
patients treated with diuretics for different indication is increasing. Various classes of 
diuretics exist, each having a unique mode of action. Diuretic therapy itself and 
disorders of serum sodium and potassium were risk factors for an adverse outcome. 
The seventh report of the joint national committee reports that 35% to 40% mean 
reductions in stroke incidence, 20% to 25% in myocardial infarction, and more that 
50% in heart failure38. It is estimated that in patients with stage I hypertension and 
additional cardiovascular risk factors, achieving a sustained 12-mm Hg decrease in 
systolic blood pressure for 10 years will prevent 1 death for every 11 patients treated. 
Diuretics are very effective in preventing stroke and coronary heart diseases. Loop 
diuretics are an integral part of heart failure management46. Thiazide diuretics were 
the first tolerated efficient anti-hypertensive drugs that significantly reduced 
cardiovascular morbidity and mortality in placebo-controlled studies. Loop diuretics 
cause thiamine deficiency by increasing urinary loss. 67% of study population had 
thiamine deficiency (whole blood free thiamine level <0.7 ng/ml).patients on diuretics 
had significantly lower thiamine level when patients on loop diuretics25.   
In the clinical setting, measurement of the electrolytes, or solutes, in the blood 
is one of the most frequently ordered laboratory tests. Interpretation of the results 
provides information about volume status, acid-base status, and baseline renal 
function. Evaluating any disequilibrium in electrolytes can be challenging and 
requires an understanding of the pathophysiology of diseases that can cause 
electrolyte imbalances; the counter-regulatory pathways of the body to correct the 
imbalance21.     
Loop diuretics were an independent risk factor for hypernatremia and 
hypokalemia, while thiazide diuretics were associated with the presence of 
hyponatremia and hypokalemia. Studies investigating diuretic therapy induced 
electrolyte disorders have mainly focused on the effects of thiazide diuretics. In a 
randomized trial in hypertensive patients, serum potassium levels were significantly 
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lower in patients treated with thiazide diuretics. The patients who did not receive 
potassium supplements developed marked hyperkalemia with potassium levels below 
3.0 mmol /L32. 
The incidence of nephrotic syndrome is about 3 new cases per 1,00,000 each 
year in adults. In a study assessing the long-term effect of metalozone in patients with 
nephrotic syndrome, loss of edema and improved control of BP was observed. 
Moreover addition of furosemide enhanced diuresis. Recent evidence from animal 
studies and clinical investigations have thrown new light on mechanisms that 
contribute to diuretic resistance in models or patients with chronic renal insufficiency 
or the nephrotic syndrome. In a study of diuretic response in heart failure patients, 
very low thiamine levels (<0.1 ng/ml) was significantly more common in patients on 
loop diuretics32. 
Diuretic use in body building reviews that diuretics increase the risk of NOD 
(New Onset Diabetes). In a network meta- analysis of 221 clinical trials, ACE 
Inhibitors, angiotensin receptor blockers, calcium channel blockers, and placebo were 
associated with a significantly lesser risk of new onset diabetes compared with 
diuretics. Studies on new insights into diuretic use in patients with chronic renal 
disease reports that an observational study of 125 patients with end stage renal disease 
treated by peritoneal dialysis showed that sodium and fluid removal by peritoneal 
dialysis were powerful predictors of a good survival. In contrast, a controlled clinical 
trial of the effects of furosemide in patients treated with continous ambulatory 
peritoneal dialysis showed no benefit of regular diuretic therapy in delaying the loss of 
residual renal function. Thus, optimal dialysis, rather than loop diuretic therapy, is the 
best treatment for these patients33. 
Understanding these disturbances can improve patient care, be cost-effective, 
prevent complications from primary disease, and ultimately reduce mortality and 
morbidity. As the adverse effects are increasing due to diuretic therapy, this study was 
planned to analyze various aspects of diuretics30. 
Objectives 
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OBJECTIVES 
  
The main objectives of the study are, 
 
 To study the utilization pattern of diuretics in the general medicine department 
and intensive care unit. 
  To monitor and detect the electrolyte disorders with diuretic therapy. 
 To identify the drug interactions and their severity. 
 
 
 
 
 
 
 
 
 
Plan of the work 
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PLAN OF THE WORK 
                      The entire study was planned to be carried out for a period of ten months 
from  november 2016 - august  2017. The proposed study was designed in four 
different phases to achieve the objectives.  
PHASE 1: 
⪼ Literature review 
⪼ Preparation of protocol 
⪼ Obtaining consent from the hospital authorities 
PHASE II: 
⪼ Preparation of patient consent form 
⪼ Designing of structured data entry format 
⪼ Data collection 
⪼ Documentation of collected data using the data entry format 
PHASE III: 
⪼ Analysis of all collected data 
⪼ Graphical representation of the data 
⪼ Interpretation of the data 
PHASE IV: 
⪼ Preparation of the project report and submission to the study department. 
 
Methodology 
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METHODOLOGY 
 
STUDY SITE  
         The proposed work entitled “Study on drug utilization pattern of diuretics at 
a tertiary care teaching hospital” was carried out in a 750 bedded multi- speciality 
institution, one of the largest hospitals in coimbatore. The various specialties include 
general medicine, anesthesiology, orthopedics, radiology, nephrology, pulmonology 
and critical care, cardiology and cardiothoracic surgery, microbiology, pathology and 
hematology, laproscopic surgery, dental and maxillofacial surgery, neurology, 
ophthalmology, physical medicine and rehabilitation, diabetology, surgical gastro 
enterology, oncology. The hospital is also equipped with the modern diagnostic 
facilities like CT scan, MRI scan, PET scan, ultrasound sonography, digital 
subtraction angiography, ECG, treadmill, colour Doppler. The hospital also has twelve 
hi-tech operation theatres, intensive care unit, intensive cardiac unit, intensive 
pulmonary care unit, catheterization, balloon valvoplasty, coronary stenting, kidney 
transplantation units like hemodialysis machines and an assisted reproductive 
technology centre. 
 
DEPARTMENT SELECTED FOR STUDY 
              The department selected for the study was intensive care unit and general 
medicine department. The reason for selection of this department was to analyze the 
indication and utilization of diuretics in different disease conditions. It was also 
identified that, the intensive care unit and general medicine department has got 
potential to use many classes of diuretic drugs. Pharmacy practice department provide 
services to the department and a good co-operation from medical team added up to the 
reason for selecting this department for conducting the study. 
 
Methodology 
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CONSENT FROM HOSPITAL AUTHORITIES 
              The protocol of the study that includes the scope of the study, objectives, 
methodology, etc was submitted to the dean of the hospital. The protocol was 
presented to the members of ethical hospital committee and the approval to carry out 
the study was obtained. The authorization from the dean to carry out the study was 
procured through his letter and the same is attached for reference in the [Annexure 1]. 
The study was conducted with the expert guidance of senior and junior physicians of 
the study department. The author was allowed to utilize the hospital facilities to make 
a follow up of the cases, in the selected department. The entire health care 
professionals were well informed through dean’s official circular. 
 
LITERATURE SURVEY 
              Literature survey was carried out regarding the different aspects that should 
be considered while doing a study based on diuretic therapy. These include use of 
diuretics in patients, class of diuretics used, diuretic- associated electrolyte disorders, 
and the therapeutic guidelines to overcome the electrolyte abnormalities. The 
literature supporting the study was gathered from various journals. 
STUDY SITE  : Intensive care unit and General medicine department 
STUDY DESIGN  : Prospective observational study. 
STUDY DURATION : 10 months (from november 2016- august 2017) 
SAMPLE SIZE  :  100 patients 
 
 PATIENT SELECTION:  
Inclusion criteria: 
 All the in-patients receiving diuretic therapy and patients willing to participate 
are included in the study. 
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Exclusion criteria: 
 Out-patients, pregnant women, pediatric patients and those not willing to 
participate in the study are excluded from the study. 
 
PATIENT CONSENT FORM 
 A patient consent form has been prepared and written consent was obtained 
from the patient  attenders. The format contains details like name, address, date, place, 
provision for signature of the patient or caregivers, investigator and supervisor. The 
same is given in [Annexure No. 2]. 
 
DATA ENTRY FORMAT 
 A specially designed data entry format was used to enter all patient’s details 
like patient name, age, sex, date of admission, date of discharge, reason for admission, 
past medical history, medication history, social history, type of diuretic prescribed, 
dose, duration, electrolyte disorders, and vital signs like BP, pulse and temperature. 
Provision is given in the format to enter the laboratory investigations like blood 
counts, blood sugar levels, liver function tests, renal function tests, urine examination, 
diagnosis, drugs prescribed, drug interactions, adverse drug reaction monitoring and  
interventions. Lipid profile were also noted down. The same is given in the 
[Annexure No. 3] for reference. 
 
METHODS AND MATERIALS 
 The data was collected during the regular ward round participation in the 
general medicine department and ICU. Standard data entry format was used to enter 
all the patient details collected during ward rounds. Patient information’s such as their 
social history, body mass index, laboratory investigations, sugar levels, blood counts, 
BP, electrolyte levels, uric acid levels and the drugs prescribed for the patients are 
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noted down from the patient’s record in the data entry format. The prescriptions were 
individually screened to assess the prevalence of diuretic therapy and associated 
electrolyte disorders. Micromedex drug data base was used to identify the drug –drug 
interactions and their severity in the prescriptions.  
 
REPORT SUBMISSION 
 The reports on the study results were prepared and the same was submitted to 
the study department.  
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TABLE NO.1 
GENDER CATEGORIZATION 
(n=100) 
Sex No. of patients Percentage (%) 
Male 65 65 
Female 35 35 
 
 
FIGURE NO.1    
AGE CATEGORIZATION 
 
 
The study results shows that 65% of the patients were male and 35% 
were female. 
 
 
 
Male  
65% 
Female  
35% 
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TABLE NO. 2 
AGE CATEGORIZATION  
(n=100) 
Age Male Female Total Percentage(%) 
 (19-35) 
 
5 5 10 10 
(36-50) 
 
11 15 26 26 
 (51-65) 
 
24 6 30 30 
 (66-74) 
 
13 7 20 20 
 (75-86) 
 
12 2 14 14 
 
FIGURE NO.2  
AGE CATEGORIZATION 
 
 
Age distribution of the patients were analyzed and it was found that 10% of the 
prescriptions were in the age group of 19-35 years, followed by 26% in the age group of  36-
50 years, 30% in the age group of 51-65 years, 20% in the age group of 66-74 years and 14% 
in the age group of  75-86 years. 
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TABLE NO.3 
SOCIAL HISTORY 
(n=100) 
S.No  Category No. of patients Percentage % 
1 Smoking+ Alcohol 23 23 
2 Smoking 17 17 
3 Alcohol 12 12 
4 Tobacco 9 9 
5 None 39 39 
                                                        
FIGURE NO.3 
SOCIAL HISTORY 
 
 
The social history of the patients reveals that 23% of study population have the habit 
of both smoking and alcohol consuming, 17% were found to be smokers, 12% were 
alcoholics and 9% were tobacco consuming. 
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12% 9% 
39% 
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TABLE NO.4 
DIAGNOSIS OBSERVED IN THE STUDY POPULATION 
(n ═100) 
No. Diagnosis No. of patients Percentage(%) 
1  Diabetes Mellitus 35 27 
2 Systemic Hypertension 30 23 
3 CAD 12 9.3 
4 RTA 7 5.4 
5 IHD 6 4.6 
6 Bronchial Asthma 4 3.1 
7 CLD 3 2.3 
8 Stroke 3 2.3 
9 ARF 2 1.6 
10 CHF 2 1.6 
11 Suicidal  2 1.6 
12 Ulcer 2 1.6 
13 Urinary Tract Infections 2 1.6 
14 Parkinson’s Disease 2 1.6 
15 Carcinoma 2 1.6 
16 Acute Kidney Injury 2 1.6 
17 CRF 1 0.1 
18 COPD 1 0.1 
19 Liver Cirrhosis 1 0.1 
20 CVA 1 0.1 
21 Others 9 6.9 
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The study results on major clinical conditions revealed that 27% were affected with 
Diabetes mellitus followed by 23% with hypertension, coronary heart disease 9.3%, renal 
disorders 4.3% and 6.9% with other clinical conditions. 
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TABLE NO.5 
THERAPEUTIC CATEGORY OF DRUGS PRESCRIBED 
(n= 1058) 
S.No Categories of drugs No. of drugs Percentage (%) 
1 Antihypertensives 203 15.21 
2 Antibiotics 126 11.91 
3 Antidiabetics 93 8.70 
4 Proton Pump Inhibitors 87 8.22 
5 NSAIDs 64 6.05 
6 Anti-anxiety 59 5.51 
7 Antiemetics 58 5.48 
8 Analgesics 45 4.25 
9 Anticonvulsants 40 3.78 
10 Potassium Supplements 30 2.83 
11 HMG-CoA Reductase Inhibitors 26 2.46 
12 Corticosteroids 26 2.46 
13 Antacids 25 2.36 
14 Anticoagulants 25 2.36 
15 CVS agents 21 0.85 
16 Neuromuscular Blockers 9 0.50 
17 Antianginals 9 0.50 
18 Antidotes 6 0.47 
19 Thrombolytics 6 0.47 
20 Anticholinergics 5 0.19 
21 Others 127 12.1 
       
The major categories of drugs in the prescriptions were anti-hypertensives (15.21%), 
antibiotics (11.91%), anti-diabetic drugs (8.70%), proton pump inhibitors (8.22%), NSAIDs 
(6.05%) and others. 
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TABLE NO.6  
ANTI-HYPERTENSIVES PRESCRIBED 
(n= 203) 
Category Number Percentage (%) 
Diuretics  122 60.09 
ACE inhibitors 22 10.84 
Beta blockers 20 9.85 
Calcium channel blockers 13 6.4 
Angiotensin receptor blockers 12 5.9 
α+β blockers 8 3.9 
Centrally acting drugs 6 2.9 
 
The study reports that 60.09% of diuretics were used in the study population, 
ACE inhibitors (10.84%), beta blockers (9.85%), calcium channel blockers (6.4%), 
angiotensin receptor blockers (5.9%), α+β blockers (3.9%), centrally acting drugs 
(2.9%). 
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TABLE NO.7  
CATEGORY OF DIURETICS PRESCRIBED 
(n=122) 
S.No Category Number Percentage (%) 
1 Loop diuretics 53 43.44 
2 Osmotic diuretics 25 20.49 
3 Thiazide diuretics 23 18.85 
4 Potassium sparing diuretics 21 17.21 
FIGURE NO.4 
CATEGORY OF DIURETICS PRESCRIBED 
(n=122) 
 
The study reveals that major diuretics used in the study population are loop 
diuretics (43.44%), osmotic diuretics (20.49%), thiazide diuretics (18.85%) and 
potassium sparing diuretics (17.21%). 
43% 
21% 
19% 
17% 
Loop Diuretics
Osmotic diuretics
Thiazide diuretics
Potassium sparing diuretics
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TABLE NO.8 
NUMBER OF DIURETICS PRESCRIBED 
(n=122) 
S.No Drugs Category No. of 
drugs 
Percentage(%) 
Monotherapy 
1 Frusemide Loop diuretic 28 22.95 
2 Torsemide Loop diuretic 25 20.49 
3 Spironolactone Potassium sparing diuretic 25 20.49 
4 Mannitol Osmotic diuretic 14 11.48 
5 Hydrochlorthiazide Thiazide diuretic 13 10.66 
6 Metolazone 
 
Thiazide diuretic 3 2.5 
Combination 
therapy 
7 Torsemide+ 
Spironolactone 
Loop diuretic+ 
Potassium sparing diuretic 
8 6.56 
8 Telmisartan+ 
Hydrochlorthoazide 
ARBs+ Potassium sparing 
diuretic 
7 5.74 
 
The study reports that the prescribed diuretics were frusemide (22.95%), 
torsemide (20.49%), spironolactone (20.49%), mannitol (11.48%), hydrochlorthiazide 
(10.66%), metolazone (2.5%) and combination therapy of diuretics include torsemide 
and spironolactone (6.56%), telmisartan and hydrochlorthiazide (5.74%). 
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TABLE NO. 9  
ELECTROLYTE DISORDERS 
(n=164) 
S.No Electrolyte Disorders Number  Percentage (%) 
1 Hyperchloremia 51 31.09 
2 Hyperbicarbonatremia 38 1.83 
3 Hypokalemia 23 14.02 
4 Hypernatremia 14 8.53 
5 Hypochloremia 14 8.53 
6 Hyponatremia 8 4.84 
7 Hyperphosphatemia 5 3.04 
8 Hypercalcemia 4 2.43 
9 Hypobicarbonatremia 3 2.21 
10 Hyperkalemia 2 1.21 
11 Hypocalcemia 1 0.06 
12 Hypermagnesemia 1 0.06 
 
The study reports that 31.09% of patients had hyperchloremia, 1.83% with 
hyperbicarbonatemia, 14.02% with hypokalemia,8.53% with  hypernatremia and 
hypochloremia, 4.84% with hyponatremia, 3.04% with hyperphosphatemia, 2.43% 
with hypercalcemia, 2.21% with hypobicarbonatemia, 1.21% with hyperkalemia, 
0.06% with hypocalcemia and hypermagnesemia. 
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TABLE NO. 10 
DRUG INTERACTIONS 
 (n=100) 
 Prescription Screened No. of  Prescription Percentage (%) 
Prescription with drug 
interaction 
60 60 
Prescription without drug 
interaction 
40 40 
 
                                                                  FIGURE NO.10 
DRUG INTERACTIONS 
(n=100) 
 
Out of 100 prescriptions, 60% of the prescription had drug interaction and 40% of the 
prescription had no drug interactions. 
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TABLE NO.11 
SEVERITY OF DRUG INTERACTIONS 
(with diuretics)  
(n= 22) 
Severity Number of Interactions Percentage (%) 
Major 13 59.09 
Moderate 6 27.27 
Minor 3 13.63 
FIGURE NO.11 
SEVERITY OF DRUG INTERACTIONS 
(with diuretics)  
(n= 22) 
 
The study states that  59.09 % were major drug interactions, 27.27% were moderate 
and 13.63% were minor drug interactions.
59% 
27% 
14% 
Major
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DISCUSSION 
The current study revealed that the number of males in study population was 
high compared to females. A similar result was published in the study done by 
Anusha N et al (2014)4 reported that there were more number of male patients than 
the female patients in the study group. By analyzing the social history of the patients, 
it was found that most of them were smokers and alcoholics. Age distribution results 
shows that majority of patients were between the age group of 51-65 years. Major 
diagnosis observed in the current study were diabetes mellitus, systemic hypertension, 
coronary artery disease and renal disorders. Results of age characterization and 
diagnosis can be compared with the study conducted by Kurnal C Solanki et al 
(2013)6 which states that maximum patients belonged to age group of 51-65 years and 
diabetes mellitus was the most common diagnosis with hypertension. 
On evaluation of prescriptions, commonly prescribed category of drugs  were 
antihypertensives, antibiotics, anti-diabetics and gastrointestinal drugs.                  
Antihypertensives account for major use followed by antibiotics, anti-diabetics and 
proton pump inhibitors. Majority of the anti  hypertensives used in the present study 
were diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor 
blockers and calcium channel blockers. A similar study  was    performed      by 
Jainaf Nachiya et al (2015)27 states that anti-hypertensives, angiotensin converting 
enzyme inhibitors and calcium channel blockers were frequently used for the 
treatment. Among diuretics prescribed, it was observed that loop diuretics accounts 
for the maximum use followed by thiazide, osmotic and potassium sparing diuretics. 
This result can be compared with the study conducted by Aram V et al (2009)38which 
states that most commonly prescribed diuretics were loop, thiazide and potassium 
sparing. 
Diuretics used as monotherapy in the study were frusemide, torsemide, 
spironolactone, mannitol, hydrochlorthiazide and metalazone. Combination therapy 
prescribed were telmisartan + hydrochlorthiazide and torsemide +spironolactone. 
Hypokalemia and hypernatremia accounts for majority of diuretic induced electrolyte 
disturbances in the study population. Other electrolyte disturbances observed in study 
Discussion 
 
Study on Drug Utilization Pattern of Diuretics at a Tertiary care teaching Hospital   43 
 
include hyperkalemia, hyponatremia, hypochloremia, hyperchloremia, 
hyperphosphotaemia, hypophosphatemia, hypomagnesemia, hypermagnesemia, 
hyperbicarbonatremia, hypobicarbonatremia, hypercalcemia and hypocalcemia. A 
similar study conducted by Spyridon Arampatzis et al (2013)30 have concluded that 
hyponatremia, hypernatremia and hyperkalemia were observed in patients receiving 
diuretic therapy.The study revealed that 60% of the prescriptions had drug 
interactions, out of which more than 50% were found to have major severity. The  
major severity was observed between spironolactone and frusemide. 
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CONCLUSION 
 Through the current study, we could assess the drug utilization pattern of 
diuretics in intensive care unit and general medicine department. The study report 
shows male population was higher compared to females. Diabetes mellitus and 
systemic hypertension were the predominal diagnosis in intensive care unit and 
general medicine department. Angiotensin converting enzyme  inhibitors and diuretics 
were the most frequently utilized drugs in the study. Among diuretics, frusemide, 
spironolactone and mannitol were highly utilized in intensive care unit and general 
medicine department. Since diuretic induced electrolyte imbalance were observed 
during the current study, the clinical pharmacist can be effectively employed to 
monitor the electrolyte levels to reduce the adverse effects. 
 Pharmacist can play an important role to avoid adverse effects associated with 
diuretics by discussing with the prescriber about drugs and their safety, alternatives, so 
that an appropriate decision is made about the patient’s therapeutic plan. The current 
study assessed the major drug interactions which were found to be highly significant. 
Identifying and monitoring drug interactions has a significant part in forming a 
standard therapeutic plan will reduce the occurrence of adverse events. 
 Understanding these disturbances can improve the patient care, be cost-
effective, prevent complications from primary disease and ultimately reduce mortality 
and morbidity30. 
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FUTURE OUTLOOK 
The present study can help to adopt a continuous electrolyte monitoring system 
in hospital to minimize the complications of electrolyte disorders. Health care 
professionals can stand as a team to know the importance of electrolyte monitoring in 
reducing the adverse effects associated with drugs prescribed. The study can be 
extended in large group of patients to analyze the electrolyte disorders. therapeutic 
guidelines can be prepared for selecting the appropriate anti-hypertensives and 
diuretics for a better patient care. Educating the patients about lifestyle modification 
of hypertension shall minimize the use of diuretics in hypertensive patients. 
Pharmacoeconomic studies on diuretics can be used for the improvement of medical 
care and cost containment and are useful for measuring or comparing the economic 
impact of drug use in specific population groups by identifying adherence to 
guidelines in the current use of medicines, it is possible to reduce drugs expenditure 
and improve the allocation of the limited resources available, when the chosen drugs 
are not usually the most cost effective. 
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